 retrospect cohort studi risk tuberculosi women age hiv infect zair risk activ tuberculosi hiv infect cohort hiv-seroposit hiv-seroneg women hiv perinat transmiss studi kinshasa zair median follow-up month new case proven pulmonari diagnos tuberculosi hiv-seroposit women case person-year hiv-seroneg women case person-year rel risk confid interv proven pulmonari tuberculosi hiv-seroposit women case person-year hiv-seroneg woman case person-year rel risk confid interv case proven pulmonari tuberculosi person-year follow-up women age hiv total incid proven pulmonari tuberculosi yr hiv-seroposit women yr follow-up none hiv-seroneg women hiv-seroposit women proven diagnos tuberculosi mortal hiv-seroposit women proven pulmonari diagnos tuberculosi follow-up hiv-seroposit women tuberculosi rel risk confid interv